>>> US Research Calls I

Research Calls I
  • Upgrades
    • Baidu (BIDU) upgraded to Outperform from Neutral at Macquarie, tgt $176
    • Beacon Financial (BBT) upgraded to Outperform from Market Perform at Keefe Bruyette, tgt $33
    • Ciena (CIEN) upgraded to Equal Weight from Underweight at Morgan Stanley, tgt $140
    • Columbia Banking (COLB) upgraded to Outperform from Market Perform at Keefe Bruyette, tgt $31
    • Core Natural Resources (CNR) upgraded to Buy from Hold at Jefferies, tgt $125
    • ESS Inc. (GWH) upgraded to Buy from Neutral at Roth Capital; tgt $3.50
    • FormFactor (FORM) upgraded to Buy from Neutral at B. Riley, tgt $47
    • Littelfuse (LFUS) upgraded to Outperform from Neutral at Robert W. Baird, tgt $310
    • nCino (NCNO) upgraded to Outperform from Market Perform at William Blair
    • OceanFirst Financial (OCFC) upgraded to Outperform from Market Perform at Keefe Bruyette, tgt $22
    • Synchrony Financial (SYF) upgraded to Buy from Hold at HSBC, tgt $81
    • TechnipFMC (FTI) upgraded to Outperform from Neutral at BNP Paribas Exane, tgt $47
    • Walker & Dunlop (WD) upgraded to Outperform from Market Perform at Citizens JMP, tgt $95
  • Downgrades
    • Align Technology (ALGN) downgraded to Hold from Buy at Jefferies, tgt $140
    • Allogene Therapeutics (ALLO) downgraded to Underweight from Neutral at JPMorgan
    • ArcelorMittal (MT) downgraded to Neutral from Buy at Goldman
    • Comerica (CMA) downgraded to Market Perform from Outperform at Keefe Bruyette, tgt $93
    • Doximity (DOCS) downgraded to Underweight from Neutral at JPMorgan, tgt $62
    • Dyne Therapeutics (DYN) downgraded to Perform from Outperform at Oppenheimer
    • HSBC Holdings (HSBC) downgraded to Hold from Buy at Jefferies
    • Keysight Technologies (KEYS) downgraded to Equal Weight from Overweight at Morgan Stanley, tgt $180
    • OR Royalties (OR) downgraded to Market Perform from Outperform at Raymond James, tgt $41
    • Pliant Therapeutics (PLRX) downgraded to Underweight from Neutral at JPMorgan
    • Saratoga Investment (SAR) downgraded to Neutral from Buy at Janney
    • Tenaris (TS) downgraded to Neutral from Outperform at BNP Paribas Exane
    • Tilray (TLRY) downgraded to Underperform from Sector Perform at ATB Capital Mkts
    • Trilogy Metals (TMQ) downgraded to Market Perform from Outperform at BMO Capital, tgt $5.50
    • Venture Global (VG) downgraded to Neutral from Outperform at Mizuho, tgt $12
  • Others
    • Abbott Laboratories (ABT) initiated with a Buy at Benchmark, tgt $145
    • Acuren (TIC) initiated with a Neutral at Robert W. Baird, tgt $15
    • Aptiv (APTV) initiated with a Buy at Citigroup, tgt $109
    • Ares Capital (ARCC) initiated with a Buy at Lucid Capital, tgt $22.50
    • Astronics (ATRO) initiated with a Buy at Craig Hallum; tgt $60
    • Cabaletta Bio (CABA) resumed with a Buy at Jefferies; tgt $14
    • Cidara Therapeutics (CDTX) initiated with an Overweight at JPMorgan, tgt $200
    • Corebridge Financial (CRBG) initiated with a Peer Perform at Wolfe Research
    • Five Star Bancorp (FSBC) initiated with a Buy at Janney
    • FTAI Aviation Ltd. (FTAI) initiated with a Buy at JonesResearch, tgt $306
    • Golar LNG (GLNG) initiated with a Buy at Citigroup, tgt $51
    • Guardian Pharmacy Services (GRDN) initiated with an Outperform at Oppenheimer, tgt $30
    • Gyre Therapeutics (GYRE) initiated with a Buy at Jefferies, tgt $16
    • Heritage Commerce (HTBK) assumed with an Overweight at Piper Sandler, tgt $11
    • Karman Holdings (KRMN) initiated with a Buy at Truist, tgt $89
    • Mannkind (MNKD) initiated with an Outperform at Leerink Partners; tgt $9
    • Morgan Stanley Direct Lending (MSDL) initiated with a Buy at Lucid Capital, tgt $18.50
    • New Mountain Finance (NMFC) initiated with a Buy at Lucid Capital, tgt $10
    • Northwest Bancshares (NWBI) initiated with a Buy at Truist, tgt $15
    • Perspective Therapeutics (CATX) initiated with a Buy at BTIG Research, tgt $14
    • StandardAero (SARO) initiated with a Buy at Truist, tgt $35
    • TAT Technologies (TATT) initiated with a Buy at JonesResearch, tgt $50
    • Viking Holdings (VIK) initiated with an Underperform at Mizuho, tgt $54
    • Weatherford International (WFRD) initiated with an Outperform at BMO Capital, tgt $82
    • Zymeworks (ZYME) initiated with a Buy at B. Riley, tgt $30